Most Recent

image: All Eyes On Stem Cells

All Eyes On Stem Cells

By | October 1, 2014

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

0 Comments

image: STW: In the Field

STW: In the Field

By | August 1, 2013

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

0 Comments

image: Making Good on Research

Making Good on Research

By | June 1, 2013

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

0 Comments

image: Photonic Colored Creatures

Photonic Colored Creatures

By | February 1, 2013

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

1 Comment

image: Game On

Game On

By | January 3, 2013

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

0 Comments

image: Of Frogs and Embryos

Of Frogs and Embryos

By | September 1, 2012

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

4 Comments

image: Surgical Art

Surgical Art

By | June 1, 2012

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

0 Comments

image: 2012 Bio-Art Winners

2012 Bio-Art Winners

By | May 25, 2012

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

0 Comments

image: A Whiff of TB

A Whiff of TB

By | March 1, 2012

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

0 Comments

image: Electron Microscopy Through the Ages

Electron Microscopy Through the Ages

By | March 1, 2012

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

8 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech